Arca
Skip to content
Tools
Tools

Amiloride-sensitive sodium channel, ENaC

Complex in Homo sapiens that 3 drugs act on.

  • Drugs that act on it: 3
  • Approved: 2
  • In phases 1 to 3: 1
  • Sponsors: 3
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on SCNN1A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved2

  • Amiloride
  • Triamterene

Phase 30

    Phase 21

    • Idrevloride

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Amiloride-sensitive sodium channel, ENaC blocker.
      AmilorideBoxed warningApprovedPadagisSmall moleculeBlocker8
      TriamtereneBoxed warningApprovedADVANZ PHARMASmall moleculeBlocker1
      IdrevloridePhase 2Parion SciencesSmall moleculeBlocker0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 9 in all, from ClinicalTrials.gov.
      Vertebrobasilar Dolichoectasia Treatment With AmilorideAmiloridePhase 2Not yet recruitingHuashan HospitalJun 8, 2026
      Beneficial Effect of Amiloride on Progression of Chronic Kidney DiseaseAmiloridePhase 2RecruitingOdense University HospitalApr 11, 2025
      ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerAmiloridePhase 2RecruitingLaura Huppert, MD, BAJan 25, 2024
      Mechanisms of Diuretic Resistance in Heart Failure, Aim 3AmiloridePhase 1RecruitingYale UniversityJan 17, 2024
      Mechanisms of Diuretic Resistance in Heart Failure, Aim 2AmiloridePhase 1RecruitingYale UniversityMar 3, 2023
      Treatment of Meniere's Disease With Migraine MedicationsTriamterenePhase 4RecruitingUniversity of California, IrvineOct 17, 2022
      AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With LithiumAmiloridePhase 4Active, not recruitingAssistance Publique - Hôpitaux de ParisSep 16, 2021
      Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine AuraAmiloridePhase 2RecruitingCentre Hospitalier Universitaire de NiceAug 21, 2019
      Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)Amiloride—Active, not recruitingUniversity of Alabama at BirminghamDec 19, 2016

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2107836, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.